During the past decade, Ente Ospedaliero Ospedali Galliera; Ambulatorio di Neurologia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ente Ospedaliero Ospedali Galliera; Ambulatorio di Neurologia" are "Alzheimer Disease" (1 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Ente Ospedaliero Ospedali Galliera; Ambulatorio di Neurologia" in a lesser frequency.

Most popular intervention types in "Ente Ospedaliero Ospedali Galliera; Ambulatorio di Neurologia" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Crenezumab" (1 trials) and "Gantenerumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ente Ospedaliero Ospedali Galliera; Ambulatorio di Neurologia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ente Ospedaliero Ospedali Galliera; Ambulatorio di Neurologia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Ente Ospedaliero Ospedali Galliera; Ambulatorio di Neurologia, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Ente Ospedaliero Ospedali Galliera; Ambulatorio di Neurologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".